University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
ChariotMS - Cladribine to Halt Deterioration in People With Advanced Multiple Sclerosis	CNS demyelinating autoimmune disease, Charcot-Marie-Tooth disease type 1F, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Active, not recruiting	Phase 2 / Phase 3	2026-09-08		NCT04695080

Clinical trials